TITLE

CANVAS 1: the first Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections

AUTHOR(S)
Corey, G. Ralph; Wilcox, Mark H.; Talbot, George H.; Thye, Dirk; Friedland, David; Baculik, Tanya
PUB. DATE
November 2010
SOURCE
Journal of Antimicrobial Chemotherapy (JAC);Nov2010 Supplement 4, Vol. 65 Issue suppl_4, piv41
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Objectives Methicillin-resistant Staphylococcus aureus (MRSA) has emerged as a common cause of complicated skin and skin structure infections (cSSSIs). Increasing antibiotic resistance and significant morbidity in cSSSIs have led to a need for new effective and safe therapies. Ceftaroline fosamil, a novel parenteral cephalosporin with excellent in vitro activity against Gram-positive pathogens, including MRSA, and many Gram-negative pathogens, was evaluated as therapy for cSSSIs in a large multicentre study. The primary study objective was to determine non-inferiority [lower limit of 95% confidence interval (CI), −10%] in the clinical cure rate achieved with ceftaroline fosamil monotherapy compared with that achieved with vancomycin plus aztreonam in the clinically evaluable (CE) and modified intent-to-treat (MITT) patient populations. Methods Adult patients with cSSSIs requiring intravenous therapy received 600 mg of ceftaroline fosamil every 12 h or 1 g of vancomycin plus 1 g of aztreonam every 12 h for 5–14 days (randomized 1 : 1). Clinical and microbiological response, adverse events (AEs) and laboratory tests were assessed. Registration number NCT00424190 (http://clinicaltrials.gov/ct2/show/NCT00424190). Results Of 702 enrolled patients, 353 received ceftaroline fosamil and 349 received vancomycin plus aztreonam. Baseline characteristics of treatment groups were comparable. Clinical cure rates were similar for ceftaroline fosamil and vancomycin plus aztreonam in the CE (91.1%, 288/316 versus 93.3%, 280/300; 95% CI, −6.6, 2.1) and MITT (86.6%, 304/351 versus 85.6%, 297/347; 95% CI, −4.2, 6.2) populations, respectively. The clinical cure rate for MRSA cSSSIs was 95.1% (78/82) for ceftaroline fosamil and 95.2% (59/62) for vancomycin plus aztreonam. The microbiological success rate was also similar for ceftaroline fosamil and vancomycin overall, and for MRSA. The rates of AEs, serious AEs, deaths and discontinuations because of an AE were similar for ceftaroline fosamil and vancomycin plus aztreonam. The most common AEs for ceftaroline fosamil and vancomycin plus aztreonam were diarrhoea (3.4% versus 3.2%), nausea (5.7% versus 4.6%), headache (5.1% versus 3.7%) and pruritus (3.1% versus 8.4%), respectively. Conclusions Ceftaroline fosamil achieved high clinical cure and microbiological success rates, was efficacious for cSSSIs caused by MRSA and other common cSSSI pathogens and was generally well tolerated. Ceftaroline fosamil has the potential to provide a monotherapy alternative for treatment of cSSSIs.
ACCESSION #
55533533

 

Related Articles

  • Neutrophils in innate host defense against Staphylococcus aureus infections. Rigby, Kevin; DeLeo, Frank // Seminars in Immunopathology;Jun2012, Vol. 34 Issue 2, p237 

    Staphylococcus aureus has been an important human pathogen throughout history and is currently a leading cause of bacterial infections worldwide. S. aureus has the unique ability to cause a continuum of diseases, ranging from minor skin infections to fatal necrotizing pneumonia. Moreover, the...

  • MRSA demands new strategies for managing infection. Krader, Cheryl Guttman; Mangan, Richard B. // Optometry Times;Aug2012, Vol. 4 Issue 8, p27 

    The article observes the rising prevalence of community-acquired methicillin-resistant Staphylococcus aureus (MRSA). It informs that the specific regimen for treating ocular infections when there is suspicion of MRSA is guided by patient risk factors and invasiveness or severity of the...

  • Molecular characteristics of community-associated methicillin-resistant Staphylococcus aureus strains for clinical medicine. Nastaly, Paulina; Grinholc, Mariusz; Bielawski, Krzysztof P. // Archives of Microbiology;Aug2010, Vol. 192 Issue 8, p603 

    Infections caused by methicillin-resistant S. aureus strains are mainly associated with a hospital setting. However, nowadays, the MRSA infections of non-hospitalized patients are observed more frequently. In order to distinguish them from hospital-associated methicillin-resistant S. aureus...

  • Boils of Summer.  // New Orleans Magazine;May2012, Vol. 46 Issue 8, p36 

    The article presents information on boils formed on the skin due to methicillin-resistant Staphylococcus aureus (MRSA). MRSA is a strain of a common bacterium resistant to many drugs including those in the penicillin family. If Staphylococcus aureus gets under the skin due to trauma or...

  • Significance of MRSA strains in community associated skin and soft tissue infections. Shenoy, M. S.; Bhat, G. K.; Kishore, A.; Hassan, M. K. // Indian Journal of Medical Microbiology;Apr2010, Vol. 28 Issue 2, p152 

    The study was conducted to determine the antibiotic susceptibility profile of community-associated methicillin resistant Staphylococcus aureus (CAMRSA) strains isolated from infections. S. aureus strains were isolated from clinical specimens using the standard procedures. CDC definition was used...

  • A survey of attitudes towards methicillin-resistant Staphylococcus aureus bacteraemias amongst United Kingdom microbiologists. Hussain, A.; Alleyne, S.; Jenkins, D. // Journal of Antimicrobial Chemotherapy (JAC);Feb2010, Vol. 65 Issue 2, p347 

    Objectives: Methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections (BSIs) in the UK are common and associated with significant morbidity and mortality. Vancomycin is the usual first-line therapy. However, vancomycin treatment of BSIs due to MRSA strains with vancomycin MICs of...

  • Methicillin-resistant Staphylococcus aureus vancomycin susceptibility testing: methodology correlations, temporal trends and clonal patterns. van Hal, Sebastiaan J.; Barbagiannakos, Thelma; Jones, Mark; Wehrhahn, Michael C.; Mercer, Joanne; Chen, Dehua; Paterson, David L.; Gosbell, Iain B. // Journal of Antimicrobial Chemotherapy (JAC);Oct2011, Vol. 66 Issue 10, p2284 

    Objectives To determine the correlation between various vancomycin MIC testing methodologies and explore the phenomenon of MIC creep. Methods A total of 417 consecutive non-duplicate methicillin-resistant Staphylococcus aureus (MRSA) bloodstream isolates from Liverpool Hospital between 1997 and...

  • Sowka Down Under, Part II. Sowka, Joseph W. // Review of Optometry;1/15/2012, Vol. 149 Issue 1, p85 

    The article offers the author's insights on the practice of optometry in the U.S. as compare with that in Australia, with regards to his visit to the country to conduct a lecture. The author highlights the difference of the two countries regarding the use of topical antibiotics, such as the...

  • Difference in epidemiology and antibiotic susceptibility of methicillin resistant and methicillin susceptible Staphylococcus aureus isolates. Saderi, Horieh; Owlia, Parviz; Nadoushan, Mohammad Reza Jalali // Iranian Journal of Clinical Infectious Diseases;Fall2009, Vol. 4 Issue 4, p219 

    Background: Antimicrobial resistance of Staphylococcus aureus especially methicillin resistant S. aureus (MRSA) continues to be a problem for clinicians worldwide. Although difference in epidemiology and antibiotic susceptibility of methicillin resistant S. aureus (MRSA) and methicillin...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics